|
Dr. DiComo is Director of Laboratories at Aureon. Charles has been with Aureon since its inception and was instrumental in the original design and build-out of the Corporate Offices and CLIA-certified Clinical Laboratories, including the Prognostic Services and R&D facilities. He has over 15 years of experience in the academic and medical research field, including a wide range of technical expertise in laboratory design, permitting and construction. Prior to joining Aureon, he served as Laboratory Head/Research Associate in the Division of Molecular Pathology at Memorial Sloan-Kettering Cancer Center (MSKCC) under the leadership of Dr. Carlos Cordon-Cardo as a Leukemia and Lymphoma Society Research Special Fellow. In this capacity, Charles managed and coordinated day-to-day operations of the molecular and histopathology laboratory, assisted in the scientific direction of Post-Doctoral Fellows, Graduate Students, and Technicians, conducted Independent Research as part of the New York p53 Consortium, and was active in developing state-of-the-art molecular pathology methodologies. Preceding MSKCC, Dr. DiComo was a Damon Runyon-Walter Winchell Fellow at Columbia University in the Department of Biological under the tutelage of Dr. Carol Prives. Charles completed his graduate studies at Cold Spring Harbor Laboratories through a joint program with SUNY. His work has been published in numerous peer-reviewed journals, such as Clinical Cancer Research, Oncogene and Cell. Charles holds a B.S. cum laude in Molecular and Cellular Biology and an M.S. in Molecular and Cellular Genetics from Long Island University - CW Post, as well as a PhD in Genetics from the State University of New York at Stony Brook. | 